E
Elham Sajjadi
Researcher at European Institute of Oncology
Publications - 57
Citations - 538
Elham Sajjadi is an academic researcher from European Institute of Oncology. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 9, co-authored 28 publications receiving 163 citations. Previous affiliations of Elham Sajjadi include Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico & Shahid Beheshti University of Medical Sciences and Health Services.
Papers
More filters
Journal ArticleDOI
PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?
Nicola Fusco,Nicola Fusco,Elham Sajjadi,Konstantinos Venetis,Konstantinos Venetis,Gabriella Gaudioso,Gianluca Lopez,Chiara Corti,Elena Guerini Rocco,Elena Guerini Rocco,Carmen Criscitiello,Umberto Malapelle,Marco Invernizzi +12 more
TL;DR: An update on the current state of knowledge on biologic and genetic alterations of PTEN across the most frequent solid tumors, as well as on their actual and/or possible clinical applications are provided.
Journal ArticleDOI
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer
Konstantinos Venetis,E. Crimini,Elham Sajjadi,Chiara Corti,Elena Guerini-Rocco,Giuseppe Viale,Giuseppe Curigliano,Carmen Criscitiello,Nicola Fusco +8 more
TL;DR: An overview of the current state of HER2 targeting in breast cancers beyond the canonical HER2 positivity is provided and the practical implications for pathologists and oncologists are discussed.
Journal ArticleDOI
Impact of Rehabilitation on Breast Cancer Related Fatigue: A Pilot Study.
Marco Invernizzi,Alessandro de Sire,Lorenzo Lippi,Konstantinos Venetis,Konstantinos Venetis,Elham Sajjadi,Francesca Gimigliano,Alessandra Gennari,Carmen Criscitiello,Carlo Cisari,Nicola Fusco,Nicola Fusco +11 more
TL;DR: The rehabilitation protocol seemed to be feasible, safe, and effective in reducing BCF, improving muscle mass and function, and improving HRQoL in a cohort of BC survivors.
Journal ArticleDOI
Characterization of the immune microenvironment in malignant pleural mesothelioma reveals prognostic subgroups of patients.
Nicola Fusco,Nicola Fusco,Valentina Vaira,Ilaria Righi,Elham Sajjadi,Konstantinos Venetis,Gianluca Lopez,M. Cattaneo,Massimo Castellani,Lorenzo Rosso,Mario Nosotti,Mario Clerici,Stefano Ferrero +12 more
TL;DR: The data show that PD-L1 expression by tumor cells or the presence of a sarcomatoid component is related to increased stromal TILs presence in MPM, and it is demonstrated that a high CD4POS/CD8POS ratio in the tumor immune microenvironment is an independent prognostic factor for survival.
Journal ArticleDOI
PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer.
Gianluca Lopez,Marianna Noale,Chiara Corti,Gabriella Gaudioso,Elham Sajjadi,Konstantinos Venetis,Donatella Gambini,Letterio Runza,Jole Costanza,Chiara Pesenti,Francesco Grossi,Stefania Maggi,Stefano Ferrero,Silvano Bosari,Nicola Fusco,Nicola Fusco +15 more
TL;DR: A novel diagnostic algorithm is proposed where PTEN expression analysis can be employed to identify pMMR breast cancers and significant correlations between MMR-proficient (pMMR), PTENexpression, and a better outcome are revealed.